Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $112.5, ...

and adjustments to ratings and price targets. Capture valuable insights into HealthEquity's market standing by understanding these analyst evaluations alongside pertinent financial indicators.

One analyst has rated the stock with a hold ... and health savings accounts. Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary ...

One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, HealthEquity has an average rating of “Moderate Buy” and an ...

Similarly, Wells Fargo analyst Stan Berenshteyn has increased the price target for Healthequity to $125, maintaining an Overweight rating. He notes several legislative bills potentially enhancing ...

HealthEquity (NASDAQ ... This is something I do want to point out as it heavily effects my BUY rating, which I will explain in the next section. So now, that we have gone through the positive ...

Shares of HealthEquity (NASDAQ ... justifying long entry,” the analyst added with a Hold rating on the stock.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Healthequity with a $121.00 average price target, representing a 28.76% upside. In a report released on March ...

Understanding Analyst Ratings: A Comprehensive Breakdown The standing of HealthEquity among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below ...

Raymond James analyst Gregory Peters upgraded Healthequity (HQY – Research Report) to a Buy yesterday and set a price target of $115.00. The ...